Steroid Detection Times

Half-Life vs Detection Time: The Critical Distinction

Half-life describes the time required for the plasma concentration of a compound to decrease by 50%. A compound with a 4-day half-life will be at 50% of peak plasma concentration after 4 days, 25% after 8 days, and effectively cleared from circulation within 20–25 days. This is a pharmacokinetic measurement — it describes what is happening to the parent compound in the bloodstream.

Detection time describes how long after the last administration a specific test method can still identify the compound or its metabolites in urine or blood. Detection time is almost always dramatically longer than the half-life, for one fundamental reason: modern anti-doping laboratories do not test for the parent compound. They test for the downstream metabolites that the body produces when metabolising the compound — and these metabolites can persist in urine for months or years after the parent compound and its primary breakdown products have fully cleared. Nandrolone Decanoate's half-life is approximately 6–12 days; its detection window in urine can reach 18 months.

The practical implication: an athlete who calculates their "clear" date based on half-life data and competes or submits to out-of-competition testing on that basis has fundamentally misunderstood how testing works. Detection time is the only number that matters for tested athletes, and it must account for metabolite persistence, not parent compound clearance.

How Anti-Doping Testing Works

WADA-accredited laboratories use several complementary detection methods depending on the compound class, testing body, and jurisdiction:

• Urine testing: The primary and most widely used modality. Urine contains concentrated metabolites of most anabolic compounds and represents the longest detection windows available. Most detection time data in the public domain refers to urine testing.
• Blood testing: Used for compounds that are difficult to detect in urine (such as Testosterone if the T/E ratio is borderline), for EPO, GH, and other peptide hormones that are cleared from urine rapidly. Blood testing typically has shorter windows for anabolic steroids than urine, but is used to detect acute use of compounds like Testosterone in conjunction with the Athlete Biological Passport (ABP).
• Longitudinal profiling (Athlete Biological Passport): Rather than testing for a specific compound, the ABP tracks multiple haematological and steroid profile markers over time. Deviations from an athlete's established individual baseline — even without a specific positive — can constitute an adverse passport finding. This means an athlete using exogenous testosterone may be flagged by the ABP even if the specific testosterone test is negative.
• Stored sample re-analysis: WADA maintains stored samples for up to 10 years, and as new detection methods are developed, previously negative samples are re-tested. This has produced retrospective positives for compounds that were undetectable at the time of original analysis.

The combination of these methods means that for professional athletes subject to WADA testing, the concept of a "safe" use window is considerably more complicated than simple detection time data suggests.

Testosterone Esters: Detection Windows

Exogenous testosterone is identified by its effect on the testosterone-to-epitestosterone (T/E) ratio and by isotope ratio mass spectrometry (IRMS) that distinguishes synthetic testosterone from endogenous. The ester attached to the testosterone molecule determines the pharmacokinetic profile, but has only a modest effect on overall detection time since testing targets both the testosterone itself and its metabolites:

• Testosterone Propionate (Testabol Propionate): Short ester, rapid clearance. Urine detection window approximately 2–3 months via metabolite testing; T/E ratio normalises faster than longer esters.
• Testosterone Enanthate (Testabol Enanthate): Medium-long ester. Detection window approximately 3 months in urine; similar to Cypionate in practical testing terms.
• Testosterone Cypionate (Testabol Depot): Detection window approximately 3 months in urine. T/E ratio may remain elevated beyond this window in some athletes; IRMS testing extends detection to 3+ months regardless of ester.

The ester length also affects how quickly HPTA suppression develops and resolves after cessation — a consideration for planning PCT relative to compound clearance, detailed at HPTA Suppression on Steroids.

Nandrolone: The Longest Detection Window

Nandrolone has by far the longest urine detection window of any anabolic compound in widespread use — and the gap between its half-life and detection time is the most dramatic example of why these two figures must never be conflated.

• Nandrolone Phenylpropionate (NPP) (Durabol 100): Half-life approximately 4–5 days. Detection window in urine: approximately 12 months. The primary metabolite 19-norandrosterone persists in urine at detectable concentrations for up to a year after the last injection.
• Nandrolone Decanoate (Decabol 250): Half-life approximately 6–12 days. Detection window in urine: up to 18 months. WADA's threshold for 19-norandrosterone in male urine is 2 ng/mL — but metabolites from a long cycle can exceed this threshold for 12–18 months post-cycle depending on cumulative dose, cycle duration, and individual metabolic rate. This makes Nandrolone Decanoate entirely incompatible with any tested sport requiring WADA compliance, at any dose, at any point during a competition season.

Trenbolone: Detection and Risk Profile

Trenbolone is not approved for human use, which means testing bodies do not apply a T/E ratio threshold approach — any detectable level is a violation. The side effect profile and detection implications of Trenbolone compounds are covered at Trenbolone Side Effects.

• Trenbolone Acetate (Trenabol 100): Short ester, half-life approximately 2–3 days. Detection window in urine: approximately 4–5 months via the primary epitrenbolone metabolite.
• Trenbolone Enanthate (Trenabol 200): Longer ester, half-life approximately 7–10 days. Detection window: approximately 5+ months. The longer depot effect means metabolites are produced over a more extended period, producing a proportionally longer detection tail.

Stanozolol: Oral vs Injectable Detection

Stanozolol presents one of the sharpest oral-versus-injectable detection time contrasts of any compound, driven by the depot effect of oil-based injectable preparations:

• Oral Stanozolol (Stanabol 50 Tablets): Rapidly absorbed and metabolised without a depot phase. Detection window in urine: approximately 3 weeks. This relatively short window has made oral Stanozolol historically popular in tested competition contexts — though testing methodology improvements continue to narrow this window.
• Injectable Stanozolol (Stanabol 50 Inj): The aqueous suspension creates a muscle depot that continues releasing active compound for weeks beyond the last injection. Detection window: approximately 9 weeks — three times longer than the oral form at comparable doses. Athletes switching from injectable to oral Stanozolol pre-competition to "shorten" their detection window may find the injectable depot extends the metabolite excretion profile regardless of the switch.

Boldenone, Methenolone, and Drostanolone

• Boldenone Undecylenate (Boldabol 200): Long undecylenate ester. Detection window approximately 4–5 months in urine. Boldenone produces a specific metabolite (boldenone itself is excreted as the glucuronide) that is not naturally occurring in humans, making identification unambiguous with no threshold applied.
• Methenolone Enanthate (Primobol Inject): Among the shorter detection windows for oil-based injectables. Detection time approximately 5 weeks in urine. This relatively short window, combined with the lowest androgenic side effect profile of any injectable anabolic — covered at Androgenic Side Effects of Steroids — makes Methenolone the most frequently used injectable anabolic among tested athletes where some risk is accepted.
• Drostanolone Propionate (Mastabol 100): Short propionate ester. Detection window approximately 3 weeks in urine — among the shortest of any injectable compound. The combination of short detection, muscle hardening effect, and no aromatisation has made Drostanolone Propionate a traditional pre-competition compound in tested bodybuilding federations with shorter testing windows.

Oxandrolone

Oxanabol Tablets (Oxandrolone) have a detection window of approximately 3 weeks in urine. This short window results from Oxandrolone's relatively straightforward hepatic metabolism without long-lived secondary metabolites at the concentrations used in performance contexts. However, a 2012 WADA study identified a longer-persisting hydroxylated metabolite detectable for up to 4 weeks at low concentrations — athletes relying on a precise 3-week clearance should account for this variation.

Detection Times Reference Table

Compound	Half-Life	Urine Detection (Approx.)
Testosterone Propionate	~2 days	~3 months
Testosterone Enanthate	~7 days	~3 months
Testosterone Cypionate	~8 days	~3 months
Nandrolone Phenylpropionate	~4–5 days	~12 months
Nandrolone Decanoate	~6–12 days	~18 months
Trenbolone Acetate	~2–3 days	~4–5 months
Trenbolone Enanthate	~7–10 days	~5+ months
Stanozolol (oral)	~9 hours	~3 weeks
Stanozolol (injectable)	~24 hours	~9 weeks
Boldenone Undecylenate	~14 days	~4–5 months
Methenolone Enanthate	~10 days	~5 weeks
Drostanolone Propionate	~2–3 days	~3 weeks
Oxandrolone	~9 hours	~3 weeks

All figures are approximate and reflect urine detection via standard metabolite testing at performance doses. Individual variation, cumulative dose, and cycle duration all affect actual detection windows. Values represent the outer expected boundary, not the average.

Factors That Affect Individual Detection Times

Published detection time data represents averages derived from controlled studies or reported positives — individual outcomes vary substantially based on:

• Cumulative dose and cycle duration: A 16-week 500 mg/week Nandrolone Decanoate cycle produces far more accumulated tissue depot and metabolite burden than a single 250 mg injection. Detection windows at higher cumulative exposure extend beyond the typical published figures.
• Individual metabolic rate: Cytochrome P450 enzyme polymorphisms vary significantly between individuals, producing two- to threefold variation in steroid metabolism rates. A fast metaboliser may clear a compound weeks earlier than a slow metaboliser at identical dose and duration.
• Renal function and urine concentration: Detection thresholds are concentration-based in urine. Higher urine flow (well-hydrated athletes) produces more dilute samples that may test below threshold earlier; concentrated samples from dehydration may extend apparent detection.
• Body fat percentage: Lipophilic compounds can accumulate in adipose tissue and release slowly over extended periods as body fat decreases. Athletes undergoing aggressive pre-competition fat loss may experience delayed metabolite excretion from mobilisation of adipose-stored compound.
• Testing methodology advances: Detection windows published 5–10 years ago consistently underestimate current capabilities. Mass spectrometry sensitivity improvements have repeatedly extended what was considered the detection limit for compounds across all classes.

PCT Timing and Detection Windows

For non-tested athletes, understanding ester clearance is relevant primarily for timing post-cycle therapy correctly — PCT should begin after exogenous androgens have cleared sufficiently to allow endogenous LH/FSH signalling to resume. The relationship between compound half-life, ester clearance, and optimal PCT start timing is covered at PCT After Steroids: Clomid, Nolvadex, HCG. For tested athletes, the detection window — not the half-life — is the governing figure, and they are rarely the same number.

Conclusion

The compounds with the shortest detection windows — oral Oxanabol Tablets, Mastabol 100, and Primobol Inject — represent the realistic toolkit for athletes who face genuine testing. The compounds with the longest windows — Decabol 250 above all, at up to 18 months — are essentially incompatible with tested competition at any point within a full year of the last injection. The fundamental principle applies universally: detection time data must always be treated as the lower bound of the real window, never the upper bound, and half-life figures tell you nothing meaningful about how long a test will find you positive.

FAQ

Q1. What is the difference between half-life and detection time for steroids?

Half-life is the time for plasma concentration of the parent compound to decrease by 50% — a pharmacokinetic measurement describing what is happening in the bloodstream. Detection time is how long after the last dose a laboratory test can still identify the compound or its metabolites in urine or blood. Detection time is almost always dramatically longer than half-life because testing targets downstream metabolites that persist long after the parent compound clears. Nandrolone Decanoate (Decabol 250) illustrates this most clearly: half-life of roughly 6–12 days, urine detection window of up to 18 months. The half-life tells you when the compound stops working; the detection time tells you when a test will be negative.

Q2. Which steroid has the longest detection time?

Nandrolone Decanoate (Decabol 250) holds the longest detection window of any compound in widespread use — approximately 18 months in urine via the primary metabolite 19-norandrosterone. Nandrolone Phenylpropionate (NPP, Durabol 100) is only slightly shorter at approximately 12 months, since both compounds produce the same metabolite. The Nandrolone family's extraordinary detection window results from the persistence of the 19-norandrosterone metabolite in urine at concentrations above WADA's 2 ng/mL threshold — not from slow clearance of the parent compound itself.

Q3. Can anything shorten steroid detection times?

No reliably effective and legal method exists for shortening steroid detection times. The metabolites that testing targets are products of normal human metabolism of the compound — they cannot be selectively eliminated without also impairing the normal metabolic processes that produce them. Probenecid was historically used as a masking agent to reduce urinary excretion of steroid metabolites; it is itself now a prohibited substance and is tested for directly. Diuretics dilute urine and can reduce metabolite concentrations temporarily, but they are also prohibited under WADA rules, are tested for, and do not reliably produce negative results on metabolites with 18-month detection windows. The only reliable approach for tested athletes is avoiding compounds with long detection windows.

Q4. Do blood tests detect steroids for longer than urine tests?

For most anabolic steroids, the opposite is true — urine testing has longer detection windows than blood for the specific metabolites that identify steroid use. Blood testing for anabolic steroids is primarily useful for detecting recent acute use (particularly with the T/E ratio for testosterone), and for compounds like GH that clear from urine rapidly but are detectable in blood for 12–24 hours post-injection. The Athlete Biological Passport combines longitudinal blood profiling with urine steroid profiling — the ABP can produce adverse findings based on deviations from individual baseline even when no specific compound is detectable in a given sample.

Q5. Which steroids have the shortest detection times for tested athletes?

The compounds with the shortest urine detection windows at performance doses are: Drostanolone Propionate (Mastabol 100) at approximately 3 weeks, oral Stanozolol (Stanabol 50 Tablets) at approximately 3 weeks, Oxandrolone (Oxanabol Tablets) at approximately 3–4 weeks, and Methenolone Enanthate (Primobol Inject) at approximately 5 weeks. These represent the realistic options for athletes who face genuine anti-doping testing and choose to accept some risk. All detection time data should be treated as lower bounds — individual metabolic variation, cumulative dose burden, improving testing sensitivity, and Athlete Biological Passport longitudinal profiling all mean that real-world detection risk extends beyond published figures.